Immunic, Inc. (IMUX) Progressive Multiple Sclerosis R&D Day: Vidofludimus Calcium Development Transcript

🇺🇸 Seeking Alpha (US) —
Immunic, Inc. (IMUX) Progressive Multiple Sclerosis R&D Day: Vidofludimus Calcium Development Transcript

AI Summary

Immunic’s R&D day focused on development of vidofludimus calcium for progressive multiple sclerosis. The supplied text provides no further trial results or development details.

Markets Health Immunic multiple sclerosis progressive MS vidofludimus calcium drug development R&D

Read original source →